LSD therapy for autism: potential, caution, and the future

The use of psychedelics in mental healthcare is making a quiet advance worldwide. While psilocybin and MDMA are already frequently in the spotlight, LSD is also starting to receive renewed attention as a potential aid for mental health issues. But what about people with autism spectrum disorder (ASD)? Can LSD contribute to greater calm, emotional processing, or social connectedness? In this article, we explore the scientific insights, practical experiences, and the Triptherapie approach regarding this topic.

What does LSD do to the brain?

LSD (lysergic acid diethylamide) influences, among other things, serotonergic signaling via the 5HT2A receptors. These receptors play a key role in neuroplasticity—the brain's ability to change and form new connections. Atypical functioning of the serotonin system is often observed in people with autism, which theoretically makes LSD an interesting candidate for therapy.

A study in Frontiers in Neuroscience discusses how LSD (and other serotonergic psychedelics) may potentially alleviate behavioral rigidity, anxiety, and social restrictions. The authors suggest that LSD restructures communication between brain regions, which can create space for new perspectives, insights, and greater emotional flexibility.

Historical and modern research

Between 1959 and 1974, several small-scale studies were already conducted in which children with ASD were administered LSD. Some results showed behavioral improvement, but the methodological limitations were significant. Only in recent years has structured research resumed.

Although LSD research specifically focused on autism is still limited, the broader field of psychedelic therapy—including that involving psilocybin and MDMA—offers hopeful indications. For example, research is currently underway into how serotonergic substances, including LSD, may influence brain functions in ASD.

LSD therapy at Triptherapie

At LSD therapy via Triptherapie LSD is offered via legal analogues. These substances have a similar effect to LSD-25 but are not covered by the Dutch Opium Act. In practice, it appears that LSD sessions can be effective for conditions including depression, anxiety disorders, and trauma. Autism is also on the radar, albeit with nuance.

Due to the long duration of effect of LSD (on average 8 to 12 hours), it is usually recommended to people who already have experience with psychedelics. For people with ASD, therefore, a psilocybin session deployed to assess how someone deals with confusion, sensory input, and introspection.

Experiences from practice

On the forum Positive experiences regarding truffle sessions for autism are being shared. What is often noticeable is that as soon as cognitive control is briefly relinquished, space is created for emotional processing and understanding — for oneself and for others. That same potential applies to LSD, provided it is properly guided and with attention to personal boundaries.

A support worker wrote about LSD: “Breaking analytical patterns in ASD requires trust and preparation. LSD is not a miracle cure, but it is a catalyst for insight and self-acceptance if the right conditions are present.”

For whom not (yet)?

LSD is not suitable for everyone. People with an increased risk of psychosis, paranoia, or extreme confusion are advised against using LSD. The use of antidepressants or antipsychotics can also be a contraindication. A thorough intake is therefore essential to limit risks and increase the chance of a positive experience.

Conclusion

LSD therapy for autism is promising, but still under development. Initial studies and practical experience show that LSD can contribute to greater emotional insight, acceptance, and social connection in individuals with ASD. At the same time, this form of therapy requires a careful approach, specialized guidance, and above all: a tailored approach. The future of psychedelic therapy for autism is hopeful—as long as we navigate this path with respect for vulnerability and neurodiversity.